Erlotinib Completed Phase 1 Trials for Cancer of the Gallbladder / Malignant Neoplasm of Pancreas / Liver Cancer / Periampullary Adenocarcinoma / Extrahepatic Bile Duct Cancer / Small Intestine Cancer Treatment

IndicationsStatusPurposePhase
CompletedTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT00987766Gemcitabine Hydrochloride, Oxaliplatin, and Erlotinib Hydrochloride in Treating Patients With Advanced Biliary Tract Cancer, Pancreatic Cancer, Duodenal Cancer, or Ampullary Cancer